Genmab A/S (GNMSF)
300.00
-8.00
(-2.60%)
USD |
OTCM |
Feb 11, 09:53
Genmab Price : 300.00 for Feb. 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Ascendis Pharma A/S | 221.19 |
| Zealand Pharma A/S | 63.84 |
| Bavarian Nordic A/S | 9.89 |
| ALK-Abello A/S | 35.80 |
Price Related Metrics
| PE Ratio | 12.76 |
| PS Ratio | 5.264 |
| PEG Ratio | 0.1010 |
| Price to Book Value | 3.213 |
| Price to Free Cash Flow | 15.46 |
| Earnings Yield | 7.83% |
| Market Cap | 18.48B |
| PEGY Ratio | 0.1010 |
| Operating PE Ratio | 14.28 |
| Normalized PE Ratio | 12.70 |